These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 21422961

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Probabilistic mapping of the health status measure SF-12 onto the health utility measure EQ-5D using the US-population-based scoring models.
    Le QA.
    Qual Life Res; 2014 Mar; 23(2):459-66. PubMed ID: 24026631
    [Abstract] [Full Text] [Related]

  • 3. Mapping ALSFRS-R and ALSUI to EQ-5D in Patients with Motor Neuron Disease.
    Moore A, Young CA, Hughes DA.
    Value Health; 2018 Nov; 21(11):1322-1329. PubMed ID: 30442280
    [Abstract] [Full Text] [Related]

  • 4. Estimating the association between SF-12 responses and EQ-5D utility values by response mapping.
    Gray AM, Rivero-Arias O, Clarke PM.
    Med Decis Making; 2006 Nov; 26(1):18-29. PubMed ID: 16495197
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Mapping the modified Rankin scale (mRS) measurement into the generic EuroQol (EQ-5D) health outcome.
    Rivero-Arias O, Ouellet M, Gray A, Wolstenholme J, Rothwell PM, Luengo-Fernandez R.
    Med Decis Making; 2010 Nov; 30(3):341-54. PubMed ID: 19858500
    [Abstract] [Full Text] [Related]

  • 12. Testing alternative regression models to predict utilities: mapping the QLQ-C30 onto the EQ-5D-5L and the SF-6D.
    Lamu AN, Olsen JA.
    Qual Life Res; 2018 Nov; 27(11):2823-2839. PubMed ID: 30173314
    [Abstract] [Full Text] [Related]

  • 13. Using the Multiple Sclerosis Impact Scale to estimate health state utility values: mapping from the MSIS-29, version 2, to the EQ-5D and the SF-6D.
    Hawton A, Green C, Telford C, Zajicek J, Wright D.
    Value Health; 2012 Dec; 15(8):1084-91. PubMed ID: 23244811
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Catalog and comparison of societal preferences (utilities) for lung cancer health states: results from the Cancer Care Outcomes Research and Surveillance (CanCORS) study.
    Tramontano AC, Schrag DL, Malin JK, Miller MC, Weeks JC, Swan JS, McMahon PM.
    Med Decis Making; 2015 Apr; 35(3):371-87. PubMed ID: 25670839
    [Abstract] [Full Text] [Related]

  • 16. Converting the SF-12 into the EQ-5D: an empirical comparison of methodologies.
    Chuang LH, Kind P.
    Pharmacoeconomics; 2009 Apr; 27(6):491-505. PubMed ID: 19640012
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.